Terminal Deoxynucleotidyl Transferase (TdT)-negative Lymphoblastic Leukemia in Pediatric Patients: Incidence and Clinical Significance.
Pediatric TdT-negative precursor B- or T-lymphoblastic leukemia/lymphoma (ALL) cases are rare and their prognostic significance remains controversial. We aimed to determine the frequency of TdT-negative ALL in the community hospital setting. Between 2005 and 2015, 43 pediatric patients were diagnosed with ALL at our Institution, of which six (14%) were characterized as TdT-negative by flow cytometric analysis. Four of these six patients had B-ALL and the other two had T-ALL. Two of the six TdT-negative patients also had undetectable CD34 expression by flow cytometry (TdT/CD34 double-negatives). Subsequent paraffin immunohistochemistry confirmed the negative CD34 expression in both cases. By contrast, all the six patients had TdT-like immunoreactivity in their marrow despite the negative flow cytometric analysis. Furthermore, neither TdT/CD34-negative cases showed myc rearrangement by FISH, ruling our Burkitt leukemia as a differential diagnostic consideration. We conclude that TdT-negative pediatric ALL cases (especially those that are TdT/CD34 double-negative) may pose diagnostic challenge to hematopathologists, and ancillary studies (paraffin immunohistochemistry to detect TdT and FISH to exclude myc rearrangement) may be instrumental in reaching the correct diagnosis.